Breaking News

Frontage Completes EU GMP Audit

Clean QP audit permits EU clinical study

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Frontage Laboratories recently completed a successful quality audit that certifies regulatory compliance and enables it to provide clinical trial materials for a client’s upcoming European Union (EU) clinical study. Known as a Qualified Person (QP) Audit, the process validates that Frontage product development, analytical testing, manufacturing facility, and quality systems are in compliance with EU GMPs. European regulations require a QP Audit to be successfully completed prior to use of clini...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters